Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...

Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.

COPD is not reversible; however, it can be controlled. Increased awareness, spirometry testing, and encouraging healthier lifestyles are paramount in reducing the burden of COPD. When detected early ...

Dr MeiLan Han, of the University of Michigan, Ann Arbor, highlights studies in chronic obstructive pulmonary disease (COPD) presented at the CHEST 2021 Annual Meeting. Dr Han first reports on a study ...

The American College of Chest Physicians (CHEST) announces a critical milestone in its long-standing advocacy to ensure ...

Discover how machine learning is helping researchers identify different groups of chronic obstructive pulmonary disease (COPD) patients in China and understand how their health conditions impact daily ...

Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...

Eosinophil Granulocytes COPD Patients with COPD who exhibit low blood eosinophil counts had no change in exacerbations or survival compared with patients with typical counts. Patients with chronic ...

The global asthma and COPD drugs market size was US$ 34522.6 million in 2021. The global asthma and COPD drugs market size is forecast to reach US$ 53049.54 million by 2030, growing at a compound ...